These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36993233)

  • 1. Discovery of a cryptic pocket in the AI-predicted structure of PPM1D phosphatase explains the binding site and potency of its allosteric inhibitors.
    Meller A; de Oliveira S; Davtyan A; Abramyan T; Bowman GR; van den Bedem H
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a cryptic pocket in the AI-predicted structure of PPM1D phosphatase explains the binding site and potency of its allosteric inhibitors.
    Meller A; De Oliveira S; Davtyan A; Abramyan T; Bowman GR; van den Bedem H
    Front Mol Biosci; 2023; 10():1171143. PubMed ID: 37143823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating Cryptic Pocket Discovery Using AlphaFold.
    Meller A; Bhakat S; Solieva S; Bowman GR
    J Chem Theory Comput; 2023 Jul; 19(14):4355-4363. PubMed ID: 36948209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators.
    Hart KM; Moeder KE; Ho CMW; Zimmerman MI; Frederick TE; Bowman GR
    PLoS One; 2017; 12(6):e0178678. PubMed ID: 28570708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state.
    Miller PG; Sathappa M; Moroco JA; Jiang W; Qian Y; Iqbal S; Guo Q; Giacomelli AO; Shaw S; Vernier C; Bajrami B; Yang X; Raffier C; Sperling AS; Gibson CJ; Kahn J; Jin C; Ranaghan M; Caliman A; Brousseau M; Fischer ES; Lintner R; Piccioni F; Campbell AJ; Root DE; Garvie CW; Ebert BL
    Nat Commun; 2022 Jun; 13(1):3778. PubMed ID: 35773251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an Allosteric Binding Site of Src Kinase Identified by Unbiased Ligand Binding Simulations.
    Mingione VR; Foda ZH; Paung Y; Philipose H; Rangwala AM; Shan Y; Seeliger MA
    J Mol Biol; 2022 Sep; 434(17):167628. PubMed ID: 35595169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
    Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug specificity and affinity are encoded in the probability of cryptic pocket opening in myosin motor domains.
    Meller A; Lotthammer JM; Smith LG; Novak B; Lee LA; Kuhn CC; Greenberg L; Leinwand LA; Greenberg MJ; Bowman GR
    Elife; 2023 Jan; 12():. PubMed ID: 36705568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure and mechanistic studies of the PPM1D serine/threonine phosphatase catalytic domain.
    Kumar JP; Kosek D; Durell SR; Miller Jenkins LM; Debnath S; Coussens NP; Hall MD; Appella DH; Dyda F; Mazur SJ; Appella E
    J Biol Chem; 2024 Jul; ():107561. PubMed ID: 39002674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets.
    Hou X; Sun JP; Ge L; Liang X; Li K; Zhang Y; Fang H
    Eur J Med Chem; 2020 Mar; 190():112131. PubMed ID: 32078861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel serotonin reuptake inhibitors targeting central and allosteric binding sites: A virtual screening and molecular dynamics simulations study.
    Erol I; Aksoydan B; Kantarcioglu I; Salmas RE; Durdagi S
    J Mol Graph Model; 2017 Jun; 74():193-202. PubMed ID: 28499269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Investigation of a Cryptic Binding Pocket of the P37 Envelope Protein of Monkeypox Virus by Molecular Dynamics Simulations.
    Sen Gupta PS; Panda SK; Nayak AK; Rana MK
    J Phys Chem Lett; 2023 Apr; 14(13):3230-3235. PubMed ID: 36972468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Analysis of Cryptic-Site Opening.
    Sun Z; Wakefield AE; Kolossvary I; Beglov D; Vajda S
    Structure; 2020 Feb; 28(2):223-235.e2. PubMed ID: 31810712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.
    Rastelli G; Anighoro A; Chripkova M; Carrassa L; Broggini M
    Cell Cycle; 2014; 13(14):2296-305. PubMed ID: 24911186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites.
    Bowman GR; Geissler PL
    Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11681-6. PubMed ID: 22753506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
    Frimurer TM; Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
    Biophys J; 2003 Apr; 84(4):2273-81. PubMed ID: 12668436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Small Molecule Inhibitors of PPM1D Using a Novel Drug Discovery Platform.
    Jiang W; Shaw S; Rush J; Dumont N; Kim J; Singh R; Skepner A; Khodier C; Raffier C; Yan N; Schluter C; Yu X; Szuchnicki M; Sathappa M; Kahn J; Sperling AS; McKinney DC; Gould AE; Garvie CW; Miller PG
    bioRxiv; 2024 May; ():. PubMed ID: 38826457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.